Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 1998

View Archived Issues

Liposomal FK-506 is effective as an immunosuppressant and antiinflammatory agent

Genentech: Q2 1998 highlights

Positive results reported from phase II trials of Provir for the treatment of watery diarrhea

Acetaminophen may be useful for the treatment of atherosclerosis

Heart attack patients demonstrate elevated matrix metalloproteinase levels

DNA vaccine provides complete protection against rabies

Kyowa Hakko discovers PDE IVA inhibitors for a range of potential indications

ADIR discovers new compounds with affinity for imidazoline receptors

Salofalk approved in Canada for the treatment of Crohn's disease

Hoechst discovers modulators of leukocyte adhesion and migration

Anti-H. pylori agents disclosed by Takeda

Antiinflammatory cytokine modulators described by Amgen

Antifungal beta-1,3-glucan synthase inhibitors discovered at Fujisawa

SmithKline Beecham discovers potent and selective beta3-adrenoceptor agonists

Rockefeller University scientists delve into the genetic roots of addiction

Intercardia sees potential conflict in its collaboration with Astra Merck

Third center begins inoculating subjects in AIDSVAX trial

BRMAC recommends approval of Stemgen for stem cell transplant patients

Draxis files for Canadian approval of oral agent for hyperparathyroidism

Future organizational structure of Degussa-Huls revealed

Japanese scientists isolate CETP inhibitors from fungal source

Menarini's NK1 antagonist MEN-11467 shows promising antiasthmatic activity

NQ-304, a novel platelet antiaggregatory and antithrombotic agent in early development

French team discovers ciproxifan, a histaminergic agent with clinical potential in AD

Profile of Solvay's dual NEP/ECE inhibitor in clinical testing

Sumitomo proves cardioprotective activity of Na+/H+ exchange inhibitor SM-20550

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...